NCIA Member Town Hall: Cannabis Rescheduling Explained
Wednesday, January 14, 2026 (3:00 PM - 4:00 PM) (EST)
Description
President Trump’s executive order instructing the Department of Justice to expedite marijuana’s reclassification under the Controlled Substances Act (CSA) arguably represents the most consequential policy shift for the cannabis industry in decades. This recent development builds off of the previous administration’s Department of Health and Human Services (HHS) recommendation to move marijuana to Schedule III and the Drug Enforcement Administration’s (DEA) initiation of the formal rulemaking process has left businesses, advocates, and policymakers alike asking: What does this all actually mean - and what happens next?
In this webinar, our panel of experts will break down the cannabis rescheduling process, explain what’s known and what’s still uncertain, and explore the real-world implications for cannabis operators, investors, state-legal markets, and federal enforcement. Attendees will gain clarity on the administrative process, potential timelines, legal and regulatory impacts, and how rescheduling fits into the broader cannabis reform landscape.
Moderator:
Michelle Rutter Friberg, Director of Government Relations, NCIA
Featured Speakers:
Kimberly Cargile, CEO, A Therapeutic Alternative
Michael Cooper, Managing Member, MadisonJay Solutions LLC | NCIA Policy Chair
Naomi Granger, Founder & CEO, NACAT Pros
Nik Komyati, Partner, Fox Rothschild
Adam Stettner, CEO, FundCanna
• This webinar is exclusive to current NCIA member employees.
• Ensure your company roster is up to date in the NCIA Info Center to verify your access.
• Non-member passes are not available for this event. Join NCIA today to gain access to this and other members-only opportunities.
Industry Essentials Webinar
72